TUM – Technical University of Munich Menu
Prof. Jürgen Ruland (right) and his research group investigate the development and suppression of lymphomas. (Image: A. Heddergott / TUM)
Prof. Jürgen Ruland (right) and his research group investigate the development and suppression of lymphomas. (Image: A. Heddergott / TUM)
  • Research news

Potential treatment approach for lymphomas triggers severe inflammations

Side effects of possible anti-cancer strategy discovered

The Malt1 protein is one of the most important control centers in human immune cells and a real all-rounder. Genetic defects in it can lead to the development of lymphatic cancer (lymphoma). A possible therapeutic approach is therefore to specifically block certain functions of Malt1, thus destroying the cancer cells. Now, however, scientists at Technische Universität München (TUM) have shown in a mouse model that such a blockade can cause serious side effects.

The Malt1 protein carries out a variety of tasks in immune cells, known as lymphocytes. Among other things, it acts as an enzyme – specifically, a protease – that breaks down messenger substances and thus controls their quantity. Until now it was not known what role the specific protease function plays in the development of immune cells. Several years ago Prof. Jürgen Ruland and his team at TUM’s Klinikum rechts der Isar turned their attention to this question.

Blockade as a therapeutic approach

The scientists were able to show in earlier cell culture experiments that a blockade of the protease function of Malt1 kills lymphoma cells. The idea was therefore conceived that this strategy could be used against lymphomas, in which Malt1 is often excessively active due to a genetic defect. “A promising therapeutic approach is believed to be the development of substances that specifically inhibit the protease function of Malt1,” explains Andreas Gewies, lead author of the study.

The next step was therefore to test this blockade strategy in an animal model in order to shed light on the exact function of Malt1 protease. “It’s only possible to study complex interactions in the immune system, which comprises a finely orchestrated interplay of various cell types, in an intact organism – not in cell cultures. The processes are too complex to recreate in cells outside the body,” says Ruland, in explanation of the step to using an animal model.

Unexpected effects in the mouse model

The mice used were genetically modified so that their Malt1 protein could no longer act as a protease but was still able to carry out all its other functions. The scientists were surprised to find that the mice developed severe signs of inflammation. Moreover, the immune system attacked and destroyed key neurons that coordinate movements. Consequently, the animals had difficulty controlling and coordinating their movements.

The scientists were able to explain how this serious malfunction of the immune system occurred and in doing so discovered an unexpected function of Malt1. They found that in the absence of the protease function, the mice were unable to produce a specific subset of lymphocytes known as regulatory T cells (Tregs). These cells are crucial for the precise control of immune responses. They ensure that immune responses are damped and, most importantly, finely controlled. Without Tregs, the mice’s immune responses went out of control.

The researchers also found that normal lymphocytes can be activated without the protease function of Malt1, but they then release messenger substances uncontrollably, which causes inflammation. “Our study showed that Malt1 protease is surprisingly important for the development of regulatory T-cells and for damping the immune response in general,“ Ruland says, summarizing the results. “Since the blockade of the protease function in the organism produces undesirable effects, new alternatives should urgently be sought for the treatment of lymphoma.”


Original publication
A. Gewies, Gorka O., Bergmann H., Pechloff K., Petermann F., Jeltsch K. M., Rudelius M., Kriegsmann M., Weichert W., Horsch M., Beckers J., Wurst W., Heikenwälder M., Korn T., Heissmeyer V. und J. Ruland, Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation, Cell Reports, 2014.
DOI: 10.1016/j.celrep.2014.10.044

Contact
Prof. Dr. Jürgen Ruland
Institute for Clinical Chemistry and Pathobiochemistry
Klinikum rechts der Isar at TUM
Tel.: +49 89 4140-4751
jruland(at)lrz.tum.de
www.klinchem.med.tum.de

Corporate Communications Center

Technical University of Munich Dr. Vera Siegler
siegler(at)zv.tum.de

Article at tum.de

Arbeiten mit Zellkulturen sind in der onkologischen Grundlagenforschung ein wichtiges Werkzeug. (Bild: A. Heddergott / TUM)

TUM coordinates two new Collaborative Research Centers

The Technical University of Munich (TUM) has taken on the role of coordinator in two new German Research Foundation Collaborative Research Centers (short SFB for german ‘Sonderforschungsbereich’), both of which are...

Roland Rad und sein Team beschäftigen sich mit der Untersuchung molekularer und translationaler Aspekte der Krebsentstehung. (Bild: A. Heddergott / TUM)

Insights into cancer evolution

Pancreatic cancer is a form of cancer associated with the highest mortality rates in the world. However, until now genetic changes that could explain the aggressiveness and early metastasis of this form of cancer had not...

Prof. Jürgen Ruland (rechts) und Dr. Tim Wartewig haben mit ihrer neuen Studie einen neuen Ansatzpunkt für Therapien gegen Lymphdrüsenkrebs gefunden. (Bild: A. Heddergott / TUM)

Shut-off switch for lymphoma

A safety switch that automatically stops the device for example before it overheats are built into many electrical appliances. The body's cells are also equipped with this kind of "emergency stop" functions. They make sure...

Professor Jürgen Ruland und eine Mitarbeiterin betrachten die Ergebnisse einer Untersuchung.

New key players found in fighting fungi

Fungal infections are a serious health risk. They can be harmful especially to patients whose immune system is compromised through illness or chemotherapy. A team working at the Technical University of Munich (TUM) has...

Dr. Christina J. Groß (links) und Dr. Ritu Mishra.

One molecule, many targets

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body. Scientists at the Technical University of Munich...

Prof. Percy Knolle (Mitte) sucht mit seinem Team am Institut für Molekulare Immunologie unter anderem nach neuen Mechanismen der Immundiagnostik. (Bild: A. Heddergott / TUM)

Cell marker enables prognosis about the course of infections

When a pathogen invades the body, specific cells in the human immune system are ready to take immediate action in order to destroy it. The molecular characteristics of these killer cells were unknown until recently. Now,...

Christoph Vahl, Erstautor der Studie, untersuchte die Tregs und die Rolle ihres T-Zell-Rezeptors. (Foto: C. Vahl / TUM)

T cell receptor ensures Treg functionality

Misdirected immune responses that target the body’s own tissue can result in human diseases. Regulatory T cells known as Tregs combat this effect by suppressing excessive immune responses and responses against our own...

Die fluoreszenzmikroskopische Aufnahme zeigt die Ubiquitin-Ligase FBXO25 (grün) und das überlebenssichernde Protein (rot) in einer Krebszelle, die gerade den Zelltod einleitet. Das gelbe Signal zeigt an, wenn beide Proteine am selben Ort sind. (Bild: F. Bassermann / TUM)

Mutations prevent programmed cell death

Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor growth. Now,...

Weil die Arbeit mit Zellen hochreine Bedingungen erfordern, tragen die Mitarbeiter in den Reinräumen sterile Bekleidung. (Foto: M. Neuenhahn / TUM)

Promising T cell therapy

When patients have to undergo a bone marrow transplant, the procedure weakens their immune system. Viruses that are usually kept in check in a healthy immune system may then cause potentially fatal infections. Scientists...

Die Abbildung zeigt eine Fluoreszenzaufnahme von Virus-DNA-Rad50-Card9-Komplexen (gelb) im Zytoplasma (Transmissionsbild) einer Zelle. Nach Infektion der Zelle mit einem DNA-Virus markieren die Wissenschaftler die einzelnen Moleküle, die sie in der Zelle beobachten möchten, mit unterschiedlichen fluoreszierenden Farbstoffen. In blau/magenta leuchtet die DNA, in grün Rad50 und in rot Card9.  (Bild: A. Rottach / LMU)

Starting signal for antiviral defense

Cells have to protect themselves: against damage in their genetic material for one thing, but also against attack from the outside, by viruses for example. They do this by using different mechanisms: special proteins search...